Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ForYourEyesOnly who wrote (225)	11/22/1997 10:56:00 AM
From: John McCarthy	of 569

THC (1) Well aware of Eduardo's thoughts. And I agree with them. (2) ANIK helps my P&L. BMY brings additional marketing $$$ and raises awareness of the new solution to osteoarthritis. Total AHP estimated penetration rate of only 1.9% for 1998. Plenty of room for ANIK. (3) If there aren't any NEWS shows (the typical News show that YOU watch) by February showing a 30 second spot about this new WONDER DRUG then I am concerned about SYNVISC and I THEN KNOW that AHP isn't a player. Whats a player? PFE:VIAGRA:COVER OF MAGAZINES ALREADY SP:ALLEGIES:ATE HMR LUNCH BMY:TOLD JAPAN GOVERNMENT TO HIT THE ROAD WITH RESPECT TO TAXOL Some up here have a strong good feeling about AHP. I don't. Why is good press important? Builds upward momentum. And reduces 2.2% problem to a footnote where it belongs. No press gives BMY an opportunity to exploit it. And they will. (4) I don't own ANIK. As you know I own tons of NPRO and am getting killed. I think 9/10 a share is cheap. I DO NOT think FDA approval is in the bag. Especially if BMY files an injunction against NPRO/FDA if FDA approves PAXENE. People are people. Regards, John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next